Menveo® Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection 0.5 mL

Name: Meningitis Vaccine
Brand: Menveo®

MENVEO VACCINE, SDV 10-5MG/0.5ML (5/CT)

McKesson #

1064517

Manufacturer #

58160095509

Brand

Menveo®

Manufacturer

Glaxo Smith Kline

Country of Origin

Unknown

Application

Meningitis Vaccine

Container Type

Single-Dose Vial

Dosage Form

Injection

Generic Drug Code

28272

Generic Drug Name

Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free

NDC Number

58160095509

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Storage Requirements

Requires Refrigeration

Strength

10 mcg - 5 mcg / 0.5 mL

Type

Intramuscular

UNSPSC Code

51201610

User

Indicated for People 2 Months to 55 Years of Age

Volume

0.5 mL

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons 2 months through 55 years of age
MENVEO is supplied in two vials that must be combined prior to administration: reconstitute the MenA lyophilized conjugate vaccine component with the MenCYW-135 liquid conjugate vaccine component immediately before administration